Anti-BRNP3/ BRINP3/ DBCCR1L functional antibody

Anti-BRNP3/ BRINP3/ DBCCR1L functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to BRINP3/BRINP3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0697-Ab-1/ GM-Tg-hg-SE0697-Ab-2Anti-Human BRINP3 monoclonal antibodyHuman
GM-Tg-rg-SE0697-Ab-1/ GM-Tg-rg-SE0697-Ab-2Anti-Rat BRINP3 monoclonal antibodyRat
GM-Tg-mg-SE0697-Ab-1/ GM-Tg-mg-SE0697-Ab-2Anti-Mouse BRINP3 monoclonal antibodyMouse
GM-Tg-cynog-SE0697-Ab-1/ GM-Tg-cynog-SE0697-Ab-2Anti-Cynomolgus/ Rhesus macaque BRINP3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0697-Ab-1/ GM-Tg-felg-SE0697-Ab-2Anti-Feline BRINP3 monoclonal antibodyFeline
GM-Tg-cang-SE0697-Ab-1/ GM-Tg-cang-SE0697-Ab-2Anti-Canine BRINP3 monoclonal antibodyCanine
GM-Tg-bovg-SE0697-Ab-1/ GM-Tg-bovg-SE0697-Ab-2Anti-Bovine BRINP3 monoclonal antibodyBovine
GM-Tg-equg-SE0697-Ab-1/ GM-Tg-equg-SE0697-Ab-2Anti-Equine BRINP3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0697-Ab-1/ GM-Tg-hg-SE0697-Ab-2; GM-Tg-rg-SE0697-Ab-1/ GM-Tg-rg-SE0697-Ab-2;
GM-Tg-mg-SE0697-Ab-1/ GM-Tg-mg-SE0697-Ab-2; GM-Tg-cynog-SE0697-Ab-1/ GM-Tg-cynog-SE0697-Ab-2;
GM-Tg-felg-SE0697-Ab-1/ GM-Tg-felg-SE0697-Ab-2; GM-Tg-cang-SE0697-Ab-1/ GM-Tg-cang-SE0697-Ab-2;
GM-Tg-bovg-SE0697-Ab-1/ GM-Tg-bovg-SE0697-Ab-2; GM-Tg-equg-SE0697-Ab-1/ GM-Tg-equg-SE0697-Ab-2
Products NameAnti-BRINP3 monoclonal antibody
Formatmab
Target NameBRINP3
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-BRINP3 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0697-Ag-1Recombinant multi-species BRNP3/ BRINP3/ DBCCR1L protein
    ORF Viral VectorpGMLP001169human BRINP3 Lentivirus plasmid
    ORF Viral VectorvGMLP001169human BRINP3 Lentivirus particle
    ORF Viral VectorpGMLPm003627mouse Brinp3 Lentivirus plasmid
    ORF Viral VectorvGMLPm003627mouse Brinp3 Lentivirus particle


    Target information

    Target IDGM-SE0697
    Target NameBRINP3
    Gene ID339479,215378,286901,713093,478959,101089978,531710,100050767
    Gene Symbol and SynonymsB830045N13Rik,BRINP3,DBCCR1L,DBCCR1L1,FAM5C
    Uniprot AccessionQ76B58,Q8K1M7
    Uniprot Entry NameBRNP3_HUMAN,BRNP3_RAT
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000162670
    Target ClassificationN/A

    The target: BRINP3, gene name: BRINP3, also named as DBCCR1L, DBCCR1L1, FAM5C. This gene is overexpressed in pituitary tumors but is underexpressed in tongue squamous cell carcinomas, ulcerative colitis, and peri-implantitis. Polymorphisms that increase expression of this gene have been shown to increase vascular inflammation, and an association of this gene with myocardial infarction has been demonstrated. Finally, hypermethylation of this gene may find usefulness as a biomarker for gastric cancer. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2015].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.